Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice

The peroxisome proliferator–activated receptor γ (PPARγ) is a nuclear receptor that regulates fat-cell development and glucose homeostasis and is the molecular target of a class of insulin-sensitizing agents used for the management of type 2 diabetes mellitus. PPARγ is highly expressed in macrophage...

全面介紹

書目詳細資料

發表在:	J Clin Invest
Principais autores:	Li, Andrew C., Brown, Kathleen K., Silvestre, Mercedes J., Willson, Timothy M., Palinski, Wulf, Glass, Christopher K.
格式:	Artigo
語言:	Inglês
出版:	American Society for Clinical Investigation 2000
主題:	Article
在線閱讀:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC380255/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10953027/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI10370
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!